Your browser doesn't support javascript.
loading
Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies.
Yeo, Winnie; Li, Leung; Lau, Thomas Kh; Lai, Kwai T; Chan, Vicky Tc; Wong, Kwan H; Yip, Christopher Ch; Pang, Elizabeth; Cheung, Maggie; Chan, Vivian; Kwok, Carol Ch; Suen, Joyce Js; Mo, Frankie Kf.
Afiliación
  • Yeo W; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.
  • Li L; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China.
  • Lau TK; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.
  • Lai KT; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.
  • Chan VT; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.
  • Wong KH; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.
  • Yip CC; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.
  • Pang E; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.
  • Cheung M; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.
  • Chan V; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.
  • Kwok CC; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.
  • Suen JJ; Department of Clinical Oncology, Princess Margaret Hospital, Hong Kong, China.
  • Mo FK; Department of Clinical Oncology, Prince of Wales Hospital, Faculty of Medicine, Hong Kong Cancer Institute, Hong Kong, China.
Cancer Biol Med ; 2021 Mar 12.
Article en En | MEDLINE | ID: mdl-33710814

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Cancer Biol Med Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Cancer Biol Med Año: 2021 Tipo del documento: Article País de afiliación: China